Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

Table 3

Clinical responses in the Rituximab and Placebo groups, and response durations for patients with significant responses, derived from self-reported Fatigue scores during 12 months follow-up.

Table 3

doi: https://doi.org/10.1371/journal.pone.0026358.t003